tenapanor 20 MG Oral Tablet

RxCUI: 2669448
RxNorm name: tenapanor 20 MG Oral Tablet
Display name: tenapanor 20 MG Oral Tablet
Full name: tenapanor 20 MG Oral Tablet
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:20

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
XPHOZAH 10 mg	TENAPANOR	Ardelyx, Inc.	c57e279c-0f1b-4238-81b7-4e0dc0cc60c5	2025-06-27	Warnings, Adverse reactions	Exact identifier rxcui: 2669448

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
c57e279c-0f1b-4238-81b7-4e0dc0cc60c5	tenapanor 20 MG Oral Tablet	PSN	17	These highlights do not include all the information needed to use XPHOZAH ® safely and effectively. See full prescribing information for XPHOZAH. XPHOZAH (tenapanor) tablets, for oral use Initial U.S. Approval: 2019	20250627
c57e279c-0f1b-4238-81b7-4e0dc0cc60c5	tenapanor 20 MG Oral Tablet	SCD	17	These highlights do not include all the information needed to use XPHOZAH ® safely and effectively. See full prescribing information for XPHOZAH. XPHOZAH (tenapanor) tablets, for oral use Initial U.S. Approval: 2019	20250627
c57e279c-0f1b-4238-81b7-4e0dc0cc60c5	tenapanor 20 MG (as tenapanor hydrochloride 21.3 MG) Oral Tablet	SY	17	These highlights do not include all the information needed to use XPHOZAH ® safely and effectively. See full prescribing information for XPHOZAH. XPHOZAH (tenapanor) tablets, for oral use Initial U.S. Approval: 2019	20250627